NauseaOlanzapineVomitingThe efficacy of olanzapine as an antiemetic agent in cancer chemotherapy has been demonstrated. However, few high-quality reports are available on the evaluation of olanzapine's efficacy and safety at a low dose of 5mg among patients treated with carboplatin regimens. Therefore,...
Smaller dosages (5 mg or 7.5 mg) can be given if these are more appropriate. Amaximum of 3 dosesmay be given if needed, 2 to 4 hours apart. Your doctor will monitor you for low blood pressure on standing (orthostatic hypotension) before giving you another dose. Tell your doctor if ...
For years, the antipsychoticolanzapine(Zyprexa, Lilly) has been used off label forchemotherapy-induced nausea and vomiting(CINV), but the currently recommended 10-mg dose causes daytime sedation. Now a phase 3 randomized controlled trial has shown that a 5-mg dose is effective at controlling CINV...
When using olanzapine and fluoxetine in combination, also refer to the Clinical Studies section of the package insert for Symbyax. Oral olanzapine should be administered in combination with fluoxetine once daily in the evening, without regard to meals, generally beginning with 5 mg of oral olanzapi...
A prospective randomized controlled trial was conducted to compare 5mg olanzapine plus standard triple antiemetic therapy for the prevention of nausea and vomiting induced by multiple-day cisplatin chemotherapy.Patients who received a 3-day cisplatin-based chemotherapy (25mg/m 2 /d) were given either...
Nausea or vomiting Dizziness, feeling lightheaded, or fainting Stomach cramps Joint pain Dark-colored pee Your skin or the whites of your eyes turning yellowish in color (also calledjaundice) Metabolism Changes.Lybalvi can cause high blood sugar levels or diabetes, high cholesterol levels, and weigh...
It is suggested that patients with diabetes and those with high risk factors for diabetes should be properly monitored. The following acute symptoms, such as sweating, insomnia, tremor, anxiety, nausea or vomiting, are rarely found in patients with sudden withdrawal of ornithine (< 0 . 01...
· Hideo Yasunaga1 Received: 19 November 2023 / Accepted: 7 August 2024 / Published online: 18 August 2024 © The Author(s) 2024 Abstract Background Olanzapine is prescribed as prophylaxis for chemotherapy-induced nausea and vomiting at a dose of 2.5 or 5 mg in Asian countries...
Dose Selection for Adjunctive Treatment When administered as adjunctive treatment to lithium or valproate, oral olanzapine dosing should generallybegin with 10 mg once-a-day without regard to meals. Antimanic efficacy was demonstrated in a dose range of 5 mg to 20 mg/day in clinical trials [see...
“Our study showed that olanzapine combined with an NK1-receptor antagonist, a 5-HT3–receptor antagonist, and dexamethasone is more effective than placebo combined with these agents for the prevention of nausea and vomiting in patients with no previous chemotherapy who are receiving highly emetogeni...